{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:42:46Z","timestamp":1762674166234,"version":"3.37.3"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T00:00:00Z","timestamp":1488240000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000402","name":"Kay Kendall Leukaemia Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA62242","AR0207265"],"award-info":[{"award-number":["CA62242","AR0207265"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0616-9","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T01:58:58Z","timestamp":1488247138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A loss of host-derived MMP-7 promotes myeloma growth and osteolytic bone disease in vivo"],"prefix":"10.1186","volume":"16","author":[{"given":"S. T.","family":"Lwin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. C.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. M.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"key":"616_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1046\/j.1432-0436.2002.700909.x","volume":"70","author":"CC Lynch","year":"2002","unstructured":"Lynch CC, Matrisian LM. Matrix metalloproteinases in tumor-host cell communication. Differentiation. 2002;70:561\u201373.","journal-title":"Differentiation"},{"key":"616_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ccr.2005.04.013","volume":"7","author":"CC Lynch","year":"2005","unstructured":"Lynch CC, Hikosaka A, Acuff HB, Martin MD, Kawai N, Singh RK, et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 2005;7:485\u201396.","journal-title":"Cancer Cell"},{"key":"616_CR3","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.1158\/0008-5472.CAN-08-3949","volume":"69","author":"S Thiolloy","year":"2009","unstructured":"Thiolloy S, Halpern J, Holt GE, Schwartz HS, Mundy GR, Matrisian LM, et al. Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Res. 2009;69:6747\u201355.","journal-title":"Cancer Res"},{"key":"616_CR4","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1158\/0008-5472.CAN-08-0537","volume":"68","author":"MD Martin","year":"2008","unstructured":"Martin MD, Carter KJ, Jean-Philippe SR, Chang M, Mobashery S, Thiolloy S, et al. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res. 2008;68:6251\u20139.","journal-title":"Cancer Res"},{"key":"616_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2613.2008.00621.x","volume":"89","author":"MJ Sinnamon","year":"2008","unstructured":"Sinnamon MJ, Carter KJ, Fingleton B, Matrisian LM. Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol. 2008;89:466\u201375.","journal-title":"Int J Exp Pathol"},{"key":"616_CR6","doi-asserted-by":"publisher","first-page":"e29862","DOI":"10.1371\/journal.pone.0029862","volume":"7","author":"S Thiolloy","year":"2012","unstructured":"Thiolloy S, Edwards JR, Fingleton B, Rifkin DB, Matrisian LM, Lynch CC. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One. 2012;7:e29862.","journal-title":"PLoS One"},{"key":"616_CR7","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1126\/science.1067100","volume":"295","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387\u201392.","journal-title":"Science"},{"key":"616_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1586\/17474086.2013.874943","volume":"7","author":"E Terpos","year":"2014","unstructured":"Terpos E, Berenson J, Raje N, Roodman GD. Management of bone disease in multiple myeloma. Expert Rev Hematol. 2014;7:113\u201325.","journal-title":"Expert Rev Hematol"},{"key":"616_CR9","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1158\/0008-5472.CAN-13-2645","volume":"74","author":"SWZ Olechnowicz","year":"2014","unstructured":"Olechnowicz SWZ, Edwards CM. Contributions of the host microenvironment to cancer-induced bone disease. Cancer Res. 2014;74:1625\u201331.","journal-title":"Cancer Res"},{"key":"616_CR10","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.leukres.2008.04.001","volume":"32","author":"B Zdzisinska","year":"2008","unstructured":"Zdzisinska B, Walter-Croneck A, Kandefer-Szerszen M. Matrix metalloproteinases-1 and \u22122, and tissue inhibitor of metalloproteinase-2 production is abnormal in bone marrow stromal cells of multiple myeloma patients. Leuk Res. 2008;32:1763\u20139.","journal-title":"Leuk Res"},{"key":"616_CR11","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1182\/blood.V90.4.1649","volume":"90","author":"S Barille","year":"1997","unstructured":"Barille S, Akhoundi C, Collette M, Mellerin MP, Rapp MJ, Harousseau JL, et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of proMMP-2, and induction of MMP-1 by myeloma cells. Blood. 1997;90:1649\u201355.","journal-title":"Blood"},{"key":"616_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1046\/j.1365-2141.1997.3893203.x","volume":"99","author":"MV Dhodapkar","year":"1997","unstructured":"Dhodapkar MV, Kelly T, Theus A, Athota AB, Barlogie B, Sanderson RD. Elevated levels of shed syndecan-1 correlate with tumour mass and decreased matrix metalloproteinase-9 activity in the serum of patients with multiple myeloma. Br J Haematol. 1997;99:368\u201371.","journal-title":"Br J Haematol"},{"key":"616_CR13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10428190009089428","volume":"37","author":"T Kelly","year":"2000","unstructured":"Kelly T, Borset M, Abe E, Gaddy-Kurten D, Sanderson RD. Matrix metalloproteinases in multiple myeloma. Leuk Lymphoma. 2000;37:273\u201381.","journal-title":"Leuk Lymphoma"},{"key":"616_CR14","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","volume":"93","author":"A Vacca","year":"1999","unstructured":"Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. 1999;93:3064\u201373.","journal-title":"Blood"},{"key":"616_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ijc.10642","volume":"101","author":"E Van Valckenborgh","year":"2002","unstructured":"Van Valckenborgh E, Bakkus M, Munaut C, Noel A, St Pierre Y, Asosingh K, et al. Upregulation of matrix metalloproteinase-9 in murine 5\u00a0T33 multiple myeloma cells by interaction with bone marrow endothelial cells. Int J Cancer. 2002;101:512\u20138.","journal-title":"Int J Cancer"},{"key":"616_CR16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0002-9440(10)63349-4","volume":"165","author":"E Van Valckenborgh","year":"2004","unstructured":"Van Valckenborgh E, Croucher PI, De Raeve H, Carron C, De Leenheer E, Blacher S, et al. Multifunctional role of matrix metalloproteinases in multiple myeloma: a study in the 5T2MM mouse model. Am J Pathol. 2004;165:869\u201378.","journal-title":"Am J Pathol"},{"key":"616_CR17","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.4049\/jimmunol.163.10.5723","volume":"163","author":"S Barille","year":"1999","unstructured":"Barille S, Bataille R, Rapp MJ, Harousseau JL, Amiot M. Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation. J Immunol. 1999;163:5723\u20138.","journal-title":"J Immunol"},{"key":"616_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1242\/dmm.003160","volume":"2","author":"JA Fowler","year":"2009","unstructured":"Fowler JA, Mundy GR, Lwin ST, Lynch CC, Edwards CM. A murine model of myeloma that allows genetic manipulation of the host microenvironment. Dis Model Mech. 2009;2:604\u201311.","journal-title":"Dis Model Mech"},{"key":"616_CR19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","volume":"93","author":"SL Dallas","year":"1999","unstructured":"Dallas SL, Garrett IR, Oyayobi BO, Dallas MR, Boyce BF, Bauss F, et al. Ibandronate reduces osteolytic lesions but not tumour burden in a murine model of myeloma bone disease. Blood. 1999;93:1697\u2013706.","journal-title":"Blood"},{"key":"616_CR20","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1182\/blood-2007-03-077685","volume":"111","author":"CM Edwards","year":"2008","unstructured":"Edwards CM, Edwards JR, Lwin ST, Esparza J, Oyajobi BO, McCluskey B, et al. Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo. Blood. 2008;111:2833\u201342.","journal-title":"Blood"},{"key":"616_CR21","doi-asserted-by":"publisher","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","volume":"118","author":"JA Fowler","year":"2011","unstructured":"Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR, et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood. 2011;118:5872\u201382.","journal-title":"Blood"},{"key":"616_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1110\/ps.072978507","volume":"16","author":"AB Hamze","year":"2007","unstructured":"Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors. Protein Sci. 2007;16:1905\u201313.","journal-title":"Protein Sci"},{"key":"616_CR23","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1172\/JCI118947","volume":"98","author":"TA Guise","year":"1996","unstructured":"Guise TA, Yin JJ, Taylor SD, Kamagai Y, Dallas M, Boyce BF, et al. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. J Clin Investig. 1996;98:1544\u20139.","journal-title":"J Clin Investig"},{"key":"616_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10555-012-9372-x","volume":"31","author":"GD Roodman","year":"2012","unstructured":"Roodman GD. Genes associate with abnormal bone cell activity in bone metastasis. Cancer Metastasis Rev. 2012;31:569\u201378.","journal-title":"Cancer Metastasis Rev"},{"key":"616_CR25","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/pros.20805","volume":"68","author":"CL Hall","year":"2008","unstructured":"Hall CL, Daignault SD, Shah RB, Pienta KJ, Keller ET. Dickkopf-1 expression increases early in prostate cancer development and decreases during progression from primary tumor to metastasis. Prostate. 2008;68:1396\u2013404.","journal-title":"Prostate"},{"key":"616_CR26","first-page":"6015","volume":"59","author":"KM Dougherty","year":"1999","unstructured":"Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, et al. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res. 1999;59:6015\u201322.","journal-title":"Cancer Res"},{"key":"616_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/(SICI)1097-0045(19990515)39:3<187::AID-PROS7>3.0.CO;2-3","volume":"39","author":"EA Blomme","year":"1999","unstructured":"Blomme EA, Dougherty KM, Pienta KJ, Capen CC, Rosol TJ, McCauley LK. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein. Prostate. 1999;39:187\u201397.","journal-title":"Prostate"},{"key":"616_CR28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/sj.bjc.6604239","volume":"98","author":"JT Korpi","year":"2008","unstructured":"Korpi JT, Kervinen V, Maklin H, Vaananen A, Lahtinen M, Laara E, et al. Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer. Br J Cancer. 2008;98:766\u201375.","journal-title":"Br J Cancer"},{"key":"616_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1399-0004.2007.00946.x","volume":"73","author":"J Decock","year":"2008","unstructured":"Decock J, Paridaens R, Ye S. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin Genet. 2008;73:197\u2013211.","journal-title":"Clin Genet"},{"key":"616_CR30","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc2228","volume":"7","author":"C Lopez-Otin","year":"2007","unstructured":"Lopez-Otin C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer. 2007;7:800\u20138.","journal-title":"Nat Rev Cancer"},{"key":"616_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1083\/jcb.200302090","volume":"162","author":"BS Wiseman","year":"2003","unstructured":"Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, et al. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol. 2003;162:1123\u201333.","journal-title":"J Cell Biol"},{"key":"616_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(00)81009-0","volume":"98","author":"MD Sternlicht","year":"1999","unstructured":"Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, et al. The stromal proteinase MMP3\/stromelysin-1 promotes mammary carcinogenesis. Cell. 1999;98:137\u201346.","journal-title":"Cell"},{"key":"616_CR33","doi-asserted-by":"publisher","first-page":"6965","DOI":"10.1158\/0008-5472.CAN-04-0910","volume":"64","author":"LJ McCawley","year":"2004","unstructured":"McCawley LJ, Crawford HC, King Jr LE, Mudgett J, Matrisian LM. A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res. 2004;64:6965\u201372.","journal-title":"Cancer Res"},{"key":"616_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"616_CR35","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1073\/pnas.94.4.1402","volume":"94","author":"CL Wilson","year":"1997","unstructured":"Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A. 1997;94:1402\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"616_CR36","doi-asserted-by":"publisher","first-page":"11760","DOI":"10.1158\/0008-5472.CAN-07-3233","volume":"67","author":"P Nangia-Makker","year":"2007","unstructured":"Nangia-Makker P, Raz T, Tait L, Hogan V, Fridman R, Raz A. Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. Cancer Res. 2007;67:11760\u20138.","journal-title":"Cancer Res"},{"key":"616_CR37","first-page":"577","volume":"61","author":"N Mitsiades","year":"2001","unstructured":"Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 2001;61:577\u201381.","journal-title":"Cancer Res"},{"key":"616_CR38","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/sj.neo.7900190","volume":"3","author":"B Fingleton","year":"2001","unstructured":"Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia. 2001;3:459\u201368.","journal-title":"Neoplasia"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0616-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-017-0616-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0616-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T11:40:12Z","timestamp":1692704412000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0616-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["616"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0616-9","relation":{},"ISSN":["1476-4598"],"issn-type":[{"type":"electronic","value":"1476-4598"}],"subject":[],"published":{"date-parts":[[2017,2,28]]},"assertion":[{"value":"19 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}